| Name | 2-{4-[4-(Trifluoromethoxy)phenyl]-1H-imidazol-2-yl}-2-propanamine | 
|---|---|
| Synonyms | 2-{4-[4-(Trifluoromethoxy)phenyl]-1H-imidazol-2-yl}-2-propanamine 1H-Imidazole-2-methanamine, α,α-dimethyl-4-[4-(trifluoromethoxy)phenyl]- MFCD26792589 | 
| Description | PF-04885614 is a potent NaV1.8 inhibitor, extracted from patent US2018328915. PF-04885614 has potential for neurological and neurodevelopmental diseases treatment[1]. | 
|---|---|
| Related Catalog | |
| References | 
| Density | 1.3±0.1 g/cm3 | 
|---|---|
| Boiling Point | 414.6±45.0 °C at 760 mmHg | 
| Molecular Formula | C13H14F3N3O | 
| Molecular Weight | 285.265 | 
| Flash Point | 204.6±28.7 °C | 
| Exact Mass | 285.108887 | 
| LogP | 3.13 | 
| Vapour Pressure | 0.0±1.0 mmHg at 25°C | 
| Index of Refraction | 1.527 |